HC Wainwright & Co. Reiterates Buy on Evolus, Maintains $27 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Evolus (NASDAQ:EOLS), maintaining a $27 price target on the stock.
March 08, 2024 | 11:56 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evolus maintains a Buy rating and a $27 price target from HC Wainwright & Co., indicating a positive outlook on the stock.
The reiteration of a Buy rating and a $27 price target by a reputable analyst firm like HC Wainwright & Co. suggests a strong belief in Evolus's potential for growth. This positive outlook is likely to influence investor sentiment and could lead to an increase in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100